Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ask the right questions!

Jaap Verweij

    European Journal of Cancer (Oxford, England : 1990)
    |February 15, 2003
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Challenges and Potential Solutions to Advance Global Cancer Drug Development.

    Therapeutic innovation & regulatory science·2026
    Same author

    Empowering effective biomarker-driven precision oncology: A call to action.

    European journal of cancer (Oxford, England : 1990)·2024
    Same author

    Correction: A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2022
    Same author

    A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2021
    Same author

    Unequal Access to Newly Registered Cancer Drugs Leads to Potential Loss of Life-Years in Europe.

    Cancers·2020
    Same author

    Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics.

    Breast cancer research and treatment·2019
    Same journal

    Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.

    European journal of cancer (Oxford, England : 1990)·2026
    Same journal

    Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphoma.

    European journal of cancer (Oxford, England : 1990)·2026
    Same journal

    Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.

    European journal of cancer (Oxford, England : 1990)·2026
    Same journal

    Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program.

    European journal of cancer (Oxford, England : 1990)·2026
    Same journal

    Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

    European journal of cancer (Oxford, England : 1990)·2026
    Same journal

    Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

    European journal of cancer (Oxford, England : 1990)·2026
    See all related articles